Artelo Biosciences
ARTL | NASDAQ
$1.70
-$0.37 (-17.87%)
At close: Nov 16, 2026, 4:00 PM ET
$1.69
-$0.01 (-0.64%)
After-hours:
Nov 16, 2026, 7:58 PM ET
-17.87%
(1D)No price chart data available for 1D timeframe.
Rating
18.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1001/1021 (Top 98%)
Key Statistics
Market Data
Market Cap $5.93M
1D Range
1.62 2.06
52W Range
1.61 94.86
Valuation (TTM)
PE -0.03
PB 0.95
EV/EBITDA -0.14
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -198.5%
SBC Adj. FCF Yield -223.5%
SBC Impact -12.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -45.5% |
-50.6%
FCF 3Y | 5Y -17.5% |
-14.7%
Returns
ROA -169.6%
ROE -272.2%
ROIC -155.7%
Financial Health
Net Cash
$4.4M
Current Ratio 10.47
Interest Coverage -19.27
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust deve...
Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jun 21, 2019
Website www.artelobio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ARTL